2001
DOI: 10.1067/mob.2001.116754
|View full text |Cite
|
Sign up to set email alerts
|

No evidence for lipid peroxidation in severe preeclampsia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
41
2
1

Year Published

2003
2003
2012
2012

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 81 publications
(48 citation statements)
references
References 24 publications
4
41
2
1
Order By: Relevance
“…4 Malondialdehyde, the most abundant reactive aldehyde derived of lipid peroxide breakdown, was one of the first biomarkers found elevated in preeclampsia. 3,28 However, in this study, representing a large sample of HDP, we did not observe any significant difference in malondialdehyde levels between hypertensive and normotensive pregnant women; published papers have shown different results in this respect as no significant difference has been described previously 29 but also other authors have found significant higher levels in preeclampsia compared with control group, with even higher levels when more severe disease. 7 As FFA levels, other important marker of lipid oxidation, were increased in all hypertensive groups compared with PCW, it is probable that the lack of differences in malondialdehyde among the groups could be explained by the small sample in which this determination was available.…”
Section: Discussioncontrasting
confidence: 70%
“…4 Malondialdehyde, the most abundant reactive aldehyde derived of lipid peroxide breakdown, was one of the first biomarkers found elevated in preeclampsia. 3,28 However, in this study, representing a large sample of HDP, we did not observe any significant difference in malondialdehyde levels between hypertensive and normotensive pregnant women; published papers have shown different results in this respect as no significant difference has been described previously 29 but also other authors have found significant higher levels in preeclampsia compared with control group, with even higher levels when more severe disease. 7 As FFA levels, other important marker of lipid oxidation, were increased in all hypertensive groups compared with PCW, it is probable that the lack of differences in malondialdehyde among the groups could be explained by the small sample in which this determination was available.…”
Section: Discussioncontrasting
confidence: 70%
“…High availability of unsaturated lipid could contribute to a predisposition to enhance lipid peroxidation. Several recent studies have reported that there is no evidence for increased lipid peroxidation in PIH (12).…”
Section: -200mentioning
confidence: 90%
“…50 A few isolated studies, however, are not supportive of a role for oxidative stress in the maternal circulation. Two found no differences in markers of lipid peroxidation in either urine (the isoprostane 8,12-epi-iPF 2␣ -VI) 51 or plasma (8-epi-prostaglandin F 2␣ and MDA) 52 . Another, although describing similar serum MDA concentrations in women with preeclampsia to controls, has nonetheless reported a higher MDA/total antioxidant capacity ratio in women with preeclampsia, which, as the authors suggested, is indicative of oxidative stress.…”
Section: The Maternal Circulationmentioning
confidence: 96%